Atlas Trials

Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of Ponesimod in Subjects With Symptomatic Chronic GVHD

Clinical trial NCT02461134 · TERMINATED

Trial details

NCT number
NCT02461134
Sponsor
Actelion
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Graft Versus Host Disease
Start date
2016-09-29
Primary completion
2017-03-02
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.